blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2395018

EP2395018 - Human binding molecules having killing activity against staphylococci and uses thereof [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.12.2016
Database last updated on 09.07.2024
Most recent event   Tooltip20.07.2018Lapse of the patent in a contracting state
New state(s): MT		published on 22.08.2018  [2018/34]
Applicant(s)For all designated states
Crucell Holland B.V.
Archimedesweg 4
2333 CN Leiden / NL
[2016/04]
Former [2011/50]For all designated states
Crucell Holland B.V.
Archimedesweg 4
2333 CN Leiden / NL
Inventor(s)01 / Throsby, Mark
Archimedesweg 4-6
2333 CN Leiden / NL
02 / Geuijen, Cecilia A.W.
Archimedesweg 4-6
2333 CN Leiden / NL
03 / De Kruif, Cornelis Adriaan
Archimedesweg 4-6
2333 CN Leiden / NL
 [2011/50]
Representative(s)Beslier, Victor
Janssen Vaccines & Prevention B.V.
Archimedesweg 4-6
2333 CN Leiden / NL
[N/P]
Former [2016/04]Beslier, Victor
Crucell Holland B.V.
IP Department
Archimedesweg 4-6
2333 CN Leiden / NL
Former [2011/50]Verhage, Richard Abraham
Crucell Holland B.V. IP Department Archimedesweg 4-6
2333 CN Leiden / NL
Application number, filing date11170742.805.06.2007
[2011/50]
Priority number, dateUS20060811477P06.06.2006         Original published format: US 811477 P
EP2006012423116.11.2006         Original published format: EP 06124231
EP2007010358406.03.2007         Original published format: EP 07103584
[2011/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2395018
Date:14.12.2011
Language:EN
[2011/50]
Type: B1 Patent specification 
No.:EP2395018
Date:27.01.2016
Language:EN
[2016/04]
Search report(s)(Supplementary) European search report - dispatched on:EP07.11.2011
ClassificationIPC:C07K16/12, C12N15/13, A61K39/40, A61P31/04
[2011/51]
CPC:
C07K16/1271 (EP,US); C07K16/12 (KR); A61K39/40 (KR);
A61P31/00 (EP); A61P31/04 (EP); A61P43/00 (EP);
C12N15/11 (KR); A61K2039/505 (EP,US); C07K2317/21 (EP,US);
C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/622 (EP,US);
C07K2317/77 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/50]
TitleGerman:Menschliche bindende Moleküle mit Abtötungswirkung gegen Staphylokokken und ihre Verwendung[2011/50]
English:Human binding molecules having killing activity against staphylococci and uses thereof[2011/50]
French:Molécules de liaison humaines dotées d'une activité de destruction de staphylocoques et leurs utilisations[2011/50]
Examination procedure21.06.2011Examination requested  [2011/50]
25.06.2012Amendment by applicant (claims and/or description)
14.12.2012Despatch of a communication from the examining division (Time limit: M08)
25.09.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
26.11.2013Reply to a communication from the examining division
20.05.2014Despatch of a communication from the examining division (Time limit: M04)
25.09.2014Reply to a communication from the examining division
16.10.2014Despatch of a communication from the examining division (Time limit: M04)
24.02.2015Reply to a communication from the examining division
28.07.2015Communication of intention to grant the patent
24.11.2015Fee for grant paid
24.11.2015Fee for publishing/printing paid
24.11.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07765322.8  / EP2027155
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070765322) is  11.08.2009
Opposition(s)28.10.2016No opposition filed within time limit [2017/01]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
26.11.2013Request for further processing filed
26.11.2013Full payment received (date of receipt of payment)
Request granted
06.12.2013Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
25.06.2012Request for further processing filed
25.06.2012Full payment received (date of receipt of payment)
Request granted
18.07.2012Decision despatched
Fees paidRenewal fee
21.06.2011Renewal fee patent year 03
21.06.2011Renewal fee patent year 04
21.06.2011Renewal fee patent year 05
31.03.2012Renewal fee patent year 06
28.05.2013Renewal fee patent year 07
31.03.2014Renewal fee patent year 08
10.06.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.01.2016
BE27.01.2016
CY27.01.2016
CZ27.01.2016
EE27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
RO27.01.2016
SK27.01.2016
TR27.01.2016
BG27.04.2016
GR28.04.2016
PT27.05.2016
MT30.06.2016
[2018/33]
Former [2018/29]AT27.01.2016
BE27.01.2016
CY27.01.2016
CZ27.01.2016
EE27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
RO27.01.2016
SK27.01.2016
TR27.01.2016
BG27.04.2016
GR28.04.2016
PT27.05.2016
Former [2017/20]AT27.01.2016
BE27.01.2016
CZ27.01.2016
EE27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
RO27.01.2016
SK27.01.2016
BG27.04.2016
GR28.04.2016
PT27.05.2016
Former [2017/03]AT27.01.2016
BE27.01.2016
CZ27.01.2016
EE27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
RO27.01.2016
SK27.01.2016
GR28.04.2016
PT27.05.2016
Former [2016/50]AT27.01.2016
CZ27.01.2016
EE27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
RO27.01.2016
SK27.01.2016
GR28.04.2016
PT27.05.2016
Former [2016/49]AT27.01.2016
EE27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
GR28.04.2016
PT27.05.2016
Former [2016/38]AT27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
GR28.04.2016
PT27.05.2016
Former [2016/36]AT27.01.2016
ES27.01.2016
IT27.01.2016
PL27.01.2016
GR28.04.2016
Former [2016/35]ES27.01.2016
GR28.04.2016
Documents cited:Search[AD]WO03059260  (BIOSYNEXUS INC [US], et al) [AD] 1-11 * the whole document, especially example 8 *;
 [AD]WO03059259  (BIOSYNEXUS INC [US], et al) [AD] 1-11* the whole document, especially example 12 *;
 [I]WO2005103084  (BRIGHAM & WOMENS HOSPITAL [US], et al) [I] 1-11 * the whole document, especially figures 7 and 12 *
by applicantWO8403564
 WO9309872
 US5696108
 WO9815833
 WO0063403
 US6265150
 WO02103012
 WO03059259
 WO03059260
 WO2004043405
 WO2005118644
    - BOEL E, VERLAAN S, POPPELIER MJ, WESTERDAAL NA, VAN STRIJP JA, LOGTENBERG T, "Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments", J. IMMUNOL. METHODS, (2000), vol. 239, doi:doi:10.1016/S0022-1759(00)00170-8, pages 153 - 166, XP004204325

DOI:   http://dx.doi.org/10.1016/S0022-1759(00)00170-8
    - BURTON DR, BARBAS CF, "Human antibodies from combinatorial libraries", ADV. IMMUNOL., (1994), vol. 57, doi:doi:10.1016/S0065-2776(08)60674-4, pages 191 - 280, XP009164108
    - CANTINIEAUX B, HARIGA C, COURTOY P, HUPIN J, FONDU P, "Staphylococcus aureus phagocytosis. A new cytofluorometric method using FITC and paraformaldehyde", J IMMUNOL. METHODS, (1989), vol. 121, doi:doi:10.1016/0022-1759(89)90161-0, pages 203 - 208, XP023653987

DOI:   http://dx.doi.org/10.1016/0022-1759(89)90161-0
    - CHOTHIA, LESK, "Canonical structures for the hypervariable regions of immunoglobulins", J. MOL. BIOL., (1987), vol. 196, doi:doi:10.1016/0022-2836(87)90412-8, pages 901 - 917, XP024010426

DOI:   http://dx.doi.org/10.1016/0022-2836(87)90412-8
    - CHOU, TC, P TALALAY, "Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors", ADV. ENZYME REGUL., (1984), vol. 22, doi:doi:10.1016/0065-2571(84)90007-4, pages 27 - 55, XP023796270

DOI:   http://dx.doi.org/10.1016/0065-2571(84)90007-4
    - DE KRUIF J, TERSTAPPEN L, BOEL E, LOGTENBERG T, "Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library", PROC. NATL. ACAD. SCI. USA, vol. 92, doi:doi:10.1073/pnas.92.9.3938, page 3938, XP002149535

DOI:   http://dx.doi.org/10.1073/pnas.92.9.3938
    - DE KRUIF J, BOEL E, LOGTENBERG T, "Selection and application of human single-chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions", J. MOL. BIOL., vol. 248, pages 97 - 105
    - HULS G, HEIJNEN IJ, CUOMO E, VAN DER LINDEN J, BOEL E, VAN DE WINKEL J, LOGTENBERG T, "Antitumor immune effector mechanisms recruited by phage display- derived fully human IgG and IgAl monoclonal antibodies", CANCER RES., (1999), vol. 59, pages 5778 - 5784
    - SLOOTSTRA JW, PUIJK WC, LIGTVOET GJ, LANGEVELD JP, MELOEN RH, "Structural aspects of antibody-antigen interaction revealed through small random peptide libraries", MOL. DIVERS, (1996), vol. 1, pages 87 - 96
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.